Illinois Municipal Retirement Fund Acquires Shares of 107,858 Hims & Hers Health, Inc. (NYSE:HIMS)

Illinois Municipal Retirement Fund bought a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS) during the 4th quarter, Holdings Channel reports. The firm bought 107,858 shares of the company’s stock, valued at approximately $2,608,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HIMS. Creative Planning raised its position in shares of Hims & Hers Health by 18.1% during the third quarter. Creative Planning now owns 25,925 shares of the company’s stock worth $478,000 after acquiring an additional 3,979 shares during the last quarter. International Assets Investment Management LLC bought a new stake in Hims & Hers Health during the 3rd quarter worth about $6,790,000. Diversify Advisory Services LLC lifted its position in Hims & Hers Health by 14.9% during the 3rd quarter. Diversify Advisory Services LLC now owns 51,828 shares of the company’s stock valued at $955,000 after purchasing an additional 6,706 shares during the period. Robeco Institutional Asset Management B.V. bought a new position in shares of Hims & Hers Health in the 3rd quarter valued at about $604,000. Finally, QRG Capital Management Inc. grew its position in shares of Hims & Hers Health by 3.9% during the 3rd quarter. QRG Capital Management Inc. now owns 162,029 shares of the company’s stock worth $2,985,000 after buying an additional 6,077 shares during the period. Institutional investors and hedge funds own 63.52% of the company’s stock.

Insider Buying and Selling at Hims & Hers Health

In other Hims & Hers Health news, insider Soleil Boughton sold 4,152 shares of the business’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $60.69, for a total transaction of $251,984.88. Following the completion of the sale, the insider now owns 157,345 shares of the company’s stock, valued at approximately $9,549,268.05. The trade was a 2.57 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Andrew Dudum sold 33,513 shares of the company’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $33.38, for a total transaction of $1,118,663.94. Following the completion of the transaction, the chief executive officer now directly owns 33,502 shares of the company’s stock, valued at $1,118,296.76. This represents a 50.01 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,097,578 shares of company stock worth $38,080,320. Company insiders own 17.71% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on HIMS shares. Leerink Partners boosted their target price on Hims & Hers Health from $24.00 to $40.00 and gave the stock a “market perform” rating in a research report on Tuesday. Piper Sandler increased their price objective on Hims & Hers Health from $24.00 to $35.00 and gave the stock a “neutral” rating in a report on Tuesday. TD Cowen reissued a “buy” rating and set a $28.00 price target on shares of Hims & Hers Health in a research report on Wednesday, November 20th. Morgan Stanley downgraded Hims & Hers Health from an “overweight” rating to an “equal weight” rating and increased their price objective for the company from $42.00 to $60.00 in a report on Tuesday, February 18th. Finally, Canaccord Genuity Group upped their target price on shares of Hims & Hers Health from $38.00 to $68.00 and gave the company a “buy” rating in a report on Wednesday, February 19th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Hims & Hers Health currently has an average rating of “Hold” and a consensus target price of $35.71.

Hims & Hers Health Stock Performance

Shares of HIMS stock opened at $41.30 on Friday. Hims & Hers Health, Inc. has a 52-week low of $11.20 and a 52-week high of $72.98. The company has a market capitalization of $9.02 billion, a PE ratio of 93.85 and a beta of 1.35. The business’s fifty day moving average is $36.19 and its 200 day moving average is $26.46.

Hims & Hers Health (NYSE:HIMS) last issued its earnings results on Monday, February 24th. The company reported $0.11 EPS for the quarter, topping the consensus estimate of $0.09 by $0.02. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. The company had revenue of $481.14 million for the quarter, compared to the consensus estimate of $494.56 million. On average, sell-side analysts forecast that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.